Study Title

Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Study Details

Description:

A neuroendocrine tumor is a rare type of tumor. It comes from body cells called neuroendocrine cells. Sometimes, these tumors develop in the gastrointestinal tract and pancreas. Researchers want to find out if a combination of drugs can shrink these tumors.

Sponsor:

National Cancer Institute

Contacts:

Joy Zou, R.N.

joy.zou@nih.gov

(240) 760-6153

Frank I Lin, M.D.

frank.lin2@nih.gov

(240) 760-6166

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468